Tuesday, April 14

Asian Penny Stocks To Watch In January 2026


As we enter January 2026, the Asian markets are capturing global attention with their mixed performance amid changing economic conditions. Penny stocks, a term that may seem outdated but remains significant, often refer to smaller or newer companies offering growth potential at lower price points. When these stocks are backed by strong financials and solid fundamentals, they can present compelling opportunities for investors seeking value and growth in under-the-radar companies.

Name

Share Price

Market Cap

Financial Health Rating

Lever Style (SEHK:1346)

HK$1.45

HK$896.85M

★★★★★★

Asia Medical and Agricultural Laboratory and Research Center (SET:AMARC)

THB2.50

THB1.05B

★★★★★★

TK Group (Holdings) (SEHK:2283)

HK$2.56

HK$2.12B

★★★★★★

Atlantic Navigation Holdings (Singapore) (Catalist:5UL)

SGD0.105

SGD54.97M

★★★★★★

Halcyon Technology (SET:HTECH)

THB2.92

THB876M

★★★★★★

Yangzijiang Shipbuilding (Holdings) (SGX:BS6)

SGD3.64

SGD14.33B

★★★★★☆

NagaCorp (SEHK:3918)

HK$4.64

HK$20.52B

★★★★★★

Livestock Improvement (NZSE:LIC)

NZ$1.00

NZ$137.01M

★★★★★★

Bosideng International Holdings (SEHK:3998)

HK$4.40

HK$51.08B

★★★★★★

Scott Technology (NZSE:SCT)

NZ$2.82

NZ$235.47M

★★★★★☆

Click here to see the full list of 958 stocks from our Asian Penny Stocks screener.

Let’s dive into some prime choices out of the screener.

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Fenbi Ltd. is an investment holding company offering non-formal vocational education and training services in the People’s Republic of China, with a market cap of HK$4.77 billion.

Operations: The company’s revenue is primarily derived from Tutoring Services, which generated CN¥2.26 billion, and Sales of books and others, contributing CN¥525.85 million.

Market Cap: HK$4.77B

Fenbi Ltd. has shown resilience with its debt-free status and strong short-term asset position, which covers both short and long-term liabilities. Despite a decline in profit margins from 13% to 7.1% over the past year, the company remains profitable with earnings forecasted to grow at 26.42% annually. Recent share repurchase announcements aim to enhance net asset value per share, potentially benefiting shareholders by up to HK$200 million worth of buybacks. However, negative earnings growth of -51% last year poses challenges against industry benchmarks, while return on equity remains low at 12.8%.

SEHK:2469 Financial Position Analysis as at Jan 2026
SEHK:2469 Financial Position Analysis as at Jan 2026

Simply Wall St Financial Health Rating: ★★★★★☆



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *